Alkem Laboratories

5,649.95
-42.80
(-0.75%)
Market Cap (₹ Cr.)
₹68,065
52 Week High
6,439.90
Book Value
₹862
52 Week Low
4,407.05
PE Ratio
31.30
PB Ratio
5.92
PE for Sector
41.08
PB for Sector
4.17
ROE
16.91 %
ROCE
41.36 %
Dividend Yield
0.70 %
EPS
₹179.80
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
9.84 %
Net Income Growth
79.93 %
Cash Flow Change
15.78 %
ROE
58.48 %
ROCE
47.24 %
EBITDA Margin (Avg.)
27.51 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
811
990
1,178
1,046
973
1,208
1,358
1,184
1,036
1,168
1,588
1,445
1,180
1,289
1,464
1,541
1,487
1,511
1,925
1,623
1,713
1,583
2,009
1,851
1,966
2,318
2,407
2,244
2,061
2,114
2,535
2,358
2,315
2,318
2,696
2,590
2,449
2,606
2,992
Expenses
654
784
882
781
767
927
1,027
940
897
993
1,126
1,109
1,080
1,090
1,137
1,212
1,230
1,233
1,410
1,233
1,334
1,044
1,390
1,336
1,514
1,728
1,776
1,709
1,807
1,875
2,056
1,841
1,906
1,919
1,980
1,977
1,970
1,880
2,144
EBITDA
157
206
295
264
206
280
331
244
139
175
463
336
100
200
327
330
257
278
516
391
380
539
619
516
452
590
631
536
254
239
479
517
409
399
716
614
479
727
848
Operating Profit %
12 %
16 %
20 %
22 %
10 %
21 %
23 %
19 %
11 %
13 %
28 %
22 %
7 %
14 %
21 %
21 %
16 %
18 %
26 %
23 %
21 %
32 %
30 %
25 %
21 %
24 %
25 %
22 %
10 %
9 %
16 %
20 %
15 %
15 %
25 %
21 %
17 %
25 %
25 %
Depreciation
17
17
21
18
18
18
19
20
20
23
26
28
30
32
33
35
41
40
40
43
64
48
52
50
49
52
54
58
55
57
58
58
57
58
59
58
69
64
63
Interest
17
20
17
15
8
5
7
7
5
8
11
7
6
10
9
7
2
9
10
10
10
12
15
9
7
9
9
7
13
22
20
23
22
21
19
21
21
21
18
Profit Before Tax
123
169
258
232
180
257
305
217
115
144
426
301
64
158
285
287
215
229
465
338
306
479
553
457
396
529
569
470
186
160
402
436
330
319
639
534
389
641
768
Tax
-27
-3
10
19
17
54
62
-98
28
30
91
82
-1
34
62
59
46
53
72
24
98
83
98
80
71
92
99
81
32
28
70
76
54
54
112
91
77
111
132
Net Profit
123
172
249
213
67
252
295
214
123
112
331
213
60
130
238
241
191
211
434
349
271
426
495
401
363
469
558
437
77
140
351
389
255
271
647
504
325
583
698
EPS in ₹
10.24
14.36
20.78
17.81
5.62
21.03
24.68
17.87
10.27
9.38
27.66
17.81
5.02
10.83
19.93
20.18
15.96
17.62
36.30
29.15
22.68
35.64
41.42
33.54
30.34
39.25
46.67
36.56
6.43
11.72
29.33
32.53
21.31
22.70
54.07
42.17
27.18
48.78
58.34

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
4,861
4,822
5,898
6,814
7,292
9,106
10,773
13,169
12,731
14,038
Fixed Assets
871
875
1,126
1,471
1,606
1,837
1,758
1,882
1,825
1,782
Current Assets
1,777
2,079
2,268
3,032
3,081
4,229
5,632
6,861
6,772
8,040
Capital Work in Progress
96
147
218
299
382
314
323
232
229
91
Investments
60
1,158
1,518
1,545
1,696
1,956
2,152
2,529
3,006
2,829
Other Assets
3,835
2,644
3,037
3,500
3,609
4,999
6,539
8,526
7,672
9,336
Total Liabilities
4,861
4,822
5,898
6,814
7,292
9,106
10,773
13,169
12,731
14,038
Current Liabilities
1,603
1,154
1,413
1,787
1,670
2,580
2,910
4,124
3,045
3,106
Non Current Liabilities
157
69
92
142
157
246
237
302
337
377
Total Equity
3,101
3,600
4,393
4,885
5,465
6,280
7,626
8,744
9,350
10,555
Reserve & Surplus
3,077
3,576
4,369
4,862
5,441
6,257
7,602
8,720
9,326
10,531
Share Capital
24
24
24
24
24
24
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
8
-18
13
-15
156
-141
-6
67
-77
-138
Investing Activities
-260
311
-362
-273
-313
-995
-1,121
-1,669
197
-866
Operating Activities
242
630
499
318
745
682
1,325
1,299
1,437
1,687
Financing Activities
26
-958
-125
-60
-276
173
-209
437
-1,711
-959

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
60.16 %
58.84 %
58.84 %
57.13 %
57.13 %
57.14 %
57.16 %
57.16 %
57.16 %
57.16 %
56.74 %
56.74 %
56.74 %
56.38 %
55.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
9.11 %
8.69 %
9.02 %
DIIs
12.97 %
14.28 %
13.78 %
13.76 %
13.93 %
13.88 %
15.26 %
16.44 %
16.69 %
15.43 %
17.64 %
14.94 %
15.63 %
18.57 %
19.21 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.75 %
21.70 %
21.15 %
22.85 %
22.63 %
22.33 %
22.28 %
21.74 %
21.44 %
20.61 %
19.36 %
18.60 %
18.31 %
16.15 %
15.84 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,795.00 4,33,931.70 38.70 49,887.20 12.06 9,648 27.34 51.02
1,541.00 1,21,755.80 26.38 26,520.70 14.17 4,155 12.95 47.09
2,600.00 1,04,826.50 49.54 10,615.60 19.57 1,942 28.89 52.27
1,224.10 1,01,936.60 19.09 28,905.40 12.36 5,578 -9.47 42.97
985.00 98,062.50 22.93 19,831.50 13.82 3,831 14.57 48.47
2,082.15 94,399.90 35.95 20,141.50 19.94 1,936 73.53 47.09
1,252.45 72,876.10 20.17 29,559.20 17.55 3,169 8.66 35.95
5,640.85 68,065.40 31.30 12,978.40 9.84 1,812 14.16 50.35
375.15 45,064.50 32.35 15,621.20 35.25 1,298 -84.31 68.22
1,551.90 43,670.00 - 12,653.10 6.58 -1,831 675.49 44.51

Corporate Action

Technical Indicators

RSI(14)
Neutral
50.35
ATR(14)
Less Volatile
161.69
STOCH(9,6)
Neutral
46.07
STOCH RSI(14)
Neutral
76.42
MACD(12,26)
Bullish
23.79
ADX(14)
Strong Trend
33.56
UO(9)
Bearish
48.78
ROC(12)
Uptrend And Accelerating
3.44
WillR(14)
Overbought
-14.94